Universal Health Services, Inc. (UHS) 10-Year Financial Performance & Capital Metrics

UHS •

HealthcareHealthcare FacilitiesHospitals and inpatient facilities

AboutUniversal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. The company operates through Acute Care Hospital Services and Behavioral Health Care Services segments. Its hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services. As of February 24, 2022, it owned and/or operated 363 inpatient facilities, and 40 outpatient and other facilities located in 39 states; Washington, D.C.; the United Kingdom; and Puerto Rico. The company also provides commercial health insurance services; and various management services, which include central purchasing, information, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. Universal Health Services, Inc. founded in 1978 and is headquartered in King of Prussia, Pennsylvania.Show more

Revenue $17.36B +9.7%
EBITDA $2.61B +15.3%
Net Income $1.49B +30.4%
EPS (Diluted) 23.10 +37.3%
Gross Margin -
EBITDA Margin 15.05% +5.1%
Operating Margin 11.48% +8.1%
Net Margin 8.57% +18.8%
ROE 21.01% +19.3%
ROIC 12.45% +13.7%
Debt/Equity 0.70 -4.8%
Interest Coverage 12.78 +42.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Good 3Y average ROE of 16.8%
✓Share count reduced 5.1% through buybacks
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.74%

5Y8.48%

3Y9.03%

TTM9.71%

Profit (Net Income) CAGR

10Y8.14%

5Y9.54%

3Y30.13%

TTM30.36%

EPS CAGR

10Y13.07%

5Y16.02%

3Y36.21%

TTM36.46%

ROCE

10Y Avg12.79%

5Y Avg12.26%

3Y Avg13.38%

Latest16.25%

Peer Comparison

Hospitals and inpatient facilities

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UHTUniversal Health Realty Income Trust	605.21M	43.62	34.35	-100%	11.84%	11.56%	8.11%
HCAHCA Healthcare, Inc.	118.45B	529.70	18.66	7.08%	8.97%		6.49%
THCTenet Healthcare Corporation	21.04B	239.39	15.45	3.12%	6.6%	15.68%	12.03%	1.47
AUNAAuna S.A.	160.71M	5.34	10.99	14.47%	4.33%	10.05%	100%	2.32
UHSUniversal Health Services, Inc.	2.58M	206.10	8.92	9.71%	8.57%	20.09%	100%	0.70
ARDTArdent Health Partners, LLC	1.34B	9.39	5.94	10.29%	3.24%	12.57%	9.51%	1.50
CYHCommunity Health Systems, Inc.	484.81M	3.46	0.92	-1.18%	4.08%		42.9%
ACHCAcadia Healthcare Company, Inc.	2.12B	23.44	-1.93	5.04%	-33.29%	-51.52%		1.23

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	9.77B	10.41B	10.77B	11.38B	11.56B	12.64B	13.4B	14.28B	15.83B	17.36B
Revenue Growth %	7.99%	6.59%	3.48%	5.63%	1.59%	9.37%	5.99%	6.59%	10.82%	9.71%
Cost of Goods Sold+	1.03B	1.11B	1.17B	1.25B	1.29B	1.43B	1.47B	1.53B	1.59B	0
COGS % of Revenue	10.56%	10.62%	10.85%	11%	11.14%	11.29%	11%	10.73%	10.03%	-
Gross Profit+	8.73B	9.3B	9.6B	10.13B	10.27B	11.21B	11.93B	12.75B	14.24B	0
Gross Margin %	89.44%	89.38%	89.15%	89%	88.86%	88.71%	89%	89.27%	89.97%	-
Gross Profit Growth %	8.25%	6.52%	3.21%	5.45%	1.42%	9.19%	6.33%	6.91%	11.69%	-100%
Operating Expenses+	7.45B	8.02B	8.43B	8.91B	8.91B	9.85B	10.92B	11.57B	12.56B	0
OpEx % of Revenue	76.32%	77.09%	78.24%	78.32%	77.1%	77.93%	81.51%	81.04%	79.34%	-
Selling, General & Admin	4.68B	5.08B	5.36B	5.7B	5.73B	6.28B	6.89B	7.25B	7.67B	0
SG&A % of Revenue	47.95%	48.84%	49.76%	50.07%	49.56%	49.7%	51.45%	50.75%	48.43%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	2.77B	2.94B	3.07B	3.21B	3.18B	3.57B	4.03B	4.33B	4.89B	0
Operating Income+	1.28B	1.28B	1.18B	1.22B	1.36B	1.36B	1B	1.18B	1.68B	1.99B
Operating Margin %	13.12%	12.3%	10.91%	10.69%	11.75%	10.78%	7.49%	8.23%	10.63%	11.48%
Operating Income Growth %	1.75%	-0.1%	-8.2%	3.46%	11.72%	0.35%	-26.38%	17.12%	43.09%	18.56%
EBITDA+	1.7B	1.73B	1.63B	1.71B	1.87B	1.9B	1.59B	1.74B	2.27B	2.61B
EBITDA Margin %	17.39%	16.6%	15.12%	15%	16.17%	15%	11.83%	12.21%	14.32%	15.05%
EBITDA Growth %	2.41%	1.76%	-5.77%	4.79%	9.53%	1.47%	-16.39%	9.97%	30.01%	15.27%
D&A (Non-Cash Add-back)	416.61M	447.76M	453.05M	490.39M	510.49M	533.21M	581.86M	568.04M	584.83M	618.74M
EBIT	1.26B	1.27B	1.18B	1.23B	1.36B	1.38B	993.15M	1.14B	1.68B	0
Net Interest Income+	-116.56M	-142.77M	-154.96M	-162.73M	-106.28M	-83.67M	-126.89M	-206.67M	-186.11M	0
Interest Income	150K	81K	0	0	2.8M	1.6M	378K	572K	1.43M	0
Interest Expense	116.72M	142.85M	154.96M	162.73M	109.09M	85.27M	127.27M	207.25M	187.53M	156.07M
Other Income/Expense	-125.05M	-145.17M	-140.74M	-149.57M	-106.27M	-69.78M	-137.29M	-234.96M	-183.88M	-21.87M
Pretax Income+	1.16B	1.14B	1.03B	1.07B	1.25B	1.29B	866.26M	940.43M	1.5B	1.97B
Pretax Margin %	11.84%	10.9%	9.6%	9.37%	10.83%	10.23%	6.46%	6.58%	9.46%	11.36%
Income Tax+	409.19M	363.7M	236.64M	238.79M	299.29M	305.68M	209.28M	221.12M	334.83M	460.96M
Effective Tax Rate %	60.74%	66.28%	75.37%	76.42%	75.39%	76.67%	77.99%	76.33%	76.24%	75.49%
Net Income+	702.41M	752.3M	779.71M	814.85M	943.95M	991.59M	675.61M	717.79M	1.14B	1.49B
Net Margin %	7.19%	7.23%	7.24%	7.16%	8.17%	7.84%	5.04%	5.03%	7.22%	8.57%
Net Income Growth %	3.22%	7.1%	3.64%	4.51%	15.84%	5.05%	-31.87%	6.24%	59.11%	30.36%
Net Income (Continuing)	747.17M	771.31M	797.88M	827.54M	952.79M	987.63M	656.98M	719.31M	1.16B	1.49B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	73.69M	68.62M	80.82M	79.1M	89.39M	108.51M	49.46M	52.91M	96.61M	70.62M
EPS (Diluted)+	7.14	7.81	8.32	9.13	10.99	11.82	9.14	10.23	16.82	23.10
EPS Growth %	5.62%	9.38%	6.53%	9.74%	20.37%	7.55%	-22.67%	11.93%	64.42%	37.34%
EPS (Basic)	7.22	7.86	8.36	9.16	11.06	11.99	9.23	10.35	17.16	23.42
Diluted Shares Outstanding	98.38M	96.33M	93.75M	89.04M	85.59M	83.69M	73.83M	70.13M	67.9M	64.46M
Basic Shares Outstanding	97.21M	95.65M	93.28M	88.76M	85.06M	82.52M	73.12M	69.32M	66.55M	63.58M
Dividend Payout Ratio	5.53%	5.08%	4.79%	6.5%	1.84%	6.65%	8.65%	7.73%	4.67%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	1.68B	1.8B	1.94B	1.92B	3.28B	2.26B	2.54B	2.81B	2.82B	3.41B
Cash & Short-Term Investments	33.75M	74.42M	105.22M	61.27M	1.22B	115.3M	102.82M	119.44M	125.98M	137.8M
Cash Only	33.75M	74.42M	105.22M	61.27M	1.22B	115.3M	102.82M	119.44M	125.98M	137.8M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	1.44B	1.5B	1.51B	1.56B	1.73B	1.75B	2.02B	2.24B	2.18B	2.6B
Days Sales Outstanding	53.8	52.63	51.16	50.07	54.6	50.43	54.96	57.2	50.22	54.7
Inventory	125.36M	136.18M	148.21M	159.89M	190.42M	206.84M	218.52M	216.99M	220.94M	0
Days Inventory Outstanding	44.37	44.98	46.29	46.64	53.96	52.9	54.1	51.67	50.79	-
Other Current Assets	82.71M	86.5M	174.47M	133.93M	138.03M	194.78M	198.28M	236.66M	291.61M	667.68M
Total Non-Current Assets+	8.64B	8.96B	9.33B	9.75B	10.2B	10.83B	10.96B	11.16B	11.65B	12.12B
Property, Plant & Equipment	4.33B	4.57B	4.85B	5.34B	5.71B	6.24B	6.37B	6.56B	6.99B	374.24M
Fixed Asset Turnover	2.25x	2.28x	2.22x	2.13x	2.02x	2.03x	2.10x	2.18x	2.26x	46.40x
Goodwill	3.78B	3.83B	3.84B	3.87B	3.88B	3.96B	3.91B	3.93B	3.93B	3.99B
Intangible Assets	0	0	0	0	0	0	0	0	76.27M	0
Long-Term Investments	0	0	0	0	0	0	0	0	318.73M	0
Other Non-Current Assets	520.13M	563.83M	629.83M	523.15M	579.97M	579.9M	605.89M	579.73M	216.19M	7.68B
Total Assets+	10.32B	10.76B	11.27B	11.67B	13.48B	13.09B	13.49B	13.97B	14.47B	15.53B
Asset Turnover	0.95x	0.97x	0.96x	0.98x	0.86x	0.97x	0.99x	1.02x	1.09x	1.12x
Asset Growth %	7.3%	4.3%	4.68%	3.58%	15.5%	-2.84%	3.06%	3.51%	3.6%	7.31%
Total Current Liabilities+	1.32B	1.85B	1.45B	1.56B	2.48B	1.98B	1.91B	2.01B	2.21B	3.24B
Accounts Payable	439.67M	441.98M	445.65M	446.96M	570.52M	658.9M	636.6M	613.97M	632M	750.13M
Days Payables Outstanding	155.6	145.98	139.19	130.37	161.66	168.52	157.6	146.2	145.28	-
Short-Term Debt	105.89M	545.62M	63.45M	87.55M	332M	48.41M	81.45M	126.69M	40.06M	821.39M
Deferred Revenue (Current)	0	0	0	0	376.15M	6K	2.4M	5.38M	0	0
Other Current Liabilities	275.29M	343.22M	472.53M	524.63M	410.17M	466.35M	470.86M	549.47M	622.63M	1.67B
Current Ratio	1.28x	0.97x	1.34x	1.23x	1.32x	1.14x	1.33x	1.40x	1.27x	1.05x
Quick Ratio	1.18x	0.90x	1.24x	1.12x	1.25x	1.04x	1.21x	1.29x	1.17x	1.05x
Cash Conversion Cycle	-57.43	-48.38	-41.74	-33.66	-53.11	-65.19	-48.54	-37.33	-44.27	-
Total Non-Current Liabilities+	4.39B	3.86B	4.35B	4.52B	4.59B	4.91B	5.61B	5.75B	5.5B	4.95B
Long-Term Debt	4.03B	3.49B	3.94B	3.9B	3.52B	4.14B	4.73B	4.79B	4.46B	4.35B
Capital Lease Obligations	0	0	0	270.08M	278.3M	304.62M	395.52M	382.56M	376.24M	0
Deferred Tax Liabilities	88.12M	54.96M	49.66M	25.07M	5.58M	0	0	0	0	5.65M
Other Non-Current Liabilities	275.17M	306.3M	361.81M	329.93M	458.55M	464.76M	487.67M	584.01M	655.81M	598.45M
Total Liabilities	5.71B	5.7B	5.8B	6.09B	7.07B	6.9B	7.52B	7.77B	7.71B	8.19B
Total Debt+	4.14B	4.04B	4B	4.31B	4.19B	4.56B	5.27B	5.37B	4.96B	5.17B
Net Debt	4.1B	3.97B	3.89B	4.25B	2.97B	4.44B	5.17B	5.25B	4.83B	5.03B
Debt / Equity	0.90x	0.80x	0.73x	0.77x	0.65x	0.74x	0.88x	0.87x	0.73x	0.70x
Debt / EBITDA	2.44x	2.34x	2.46x	2.53x	2.24x	2.40x	3.32x	3.08x	2.19x	1.98x
Net Debt / EBITDA	2.42x	2.29x	2.39x	2.49x	1.59x	2.34x	3.26x	3.01x	2.13x	1.92x
Interest Coverage	10.98x	8.96x	7.58x	7.47x	12.45x	15.99x	7.89x	5.67x	8.97x	12.78x
Total Equity+	4.61B	5.06B	5.47B	5.58B	6.41B	6.2B	5.97B	6.2B	6.76B	7.41B
Equity Growth %	1.21%	9.79%	8.14%	2.07%	14.75%	-3.25%	-3.68%	3.88%	9.04%	9.56%
Book Value per Share	46.83	52.51	58.35	62.70	74.85	74.06	80.86	88.44	99.61	114.94
Total Shareholders' Equity	4.53B	4.99B	5.39B	5.5B	6.32B	6.09B	5.92B	6.15B	6.67B	7.34B
Common Stock	966K	942K	914K	867K	851K	771K	710K	672K	650K	7.28B
Retained Earnings	4.89B	4.98B	5.38B	5.47B	6.27B	6.06B	5.93B	6.8B	7.37B	7.99B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-359.02M	7.18M	4.24M	31.89M	48.12M	30.29M	-9.67M	-650.6M	-706.5M	47.78M
Minority Interest	73.69M	68.62M	80.82M	79.1M	89.39M	108.51M	49.46M	52.91M	96.61M	70.62M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	1.29B	1.18B	1.34B	1.44B	2.36B	883.7M	996.02M	1.27B	2.07B	1.86B
Operating CF Margin %	13.19%	11.36%	12.45%	12.64%	20.42%	6.99%	7.43%	8.88%	13.06%	10.74%
Operating CF Growth %	26.21%	-8.22%	13.39%	7.28%	64.08%	-62.56%	12.71%	27.29%	63.05%	-9.81%
Net Income	747.17M	771.31M	797.88M	827.54M	952.79M	987.63M	656.98M	717.49M	1.16B	1.51B
Depreciation & Amortization	416.61M	447.88M	453.08M	490.39M	510.49M	533.21M	581.86M	568.04M	584.83M	618.74M
Stock-Based Compensation	48.11M	56.74M	66.58M	69.43M	65.84M	73.69M	85.38M	87.72M	99.35M	95.69M
Deferred Taxes	47.36M	0	49.52M	90.09M	3.32M	26.05M	0	0	0	0
Other Non-Cash Items	-129.33M	-79.19M	-76.15M	-97.78M	-109.76M	0	-83.85M	-124.34M	-198.95M	-361.22M
Working Capital Changes	158.55M	-14.16M	49.98M	58.79M	940.81M	-736.89M	-244.35M	17.07M	418.76M	0
Change in Receivables	-87.88M	-24.72M	-42.24M	-42.06M	-145.9M	-8.87M	-258.34M	-182.44M	67.36M	-317.99M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0
Cash from Investing+	-1.19B	-624.4M	-813.4M	-688.41M	-802.56M	-914.47M	-647.3M	-763.27M	-911.11M	-1.07B
Capital Expenditures	-1.16B	-609.43M	-811.67M	-663.52M	-734.21M	-855.66M	-734M	-743.05M	-943.81M	-1.02B
CapEx % of Revenue	11.83%	5.85%	7.53%	5.83%	6.35%	6.77%	5.48%	5.2%	5.96%	5.85%
Acquisitions	-32M	-15.08M	-15.23M	-14.58M	-54.78M	-105.31M	-20.31M	-3.73M	-18.72M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-32M	108K	13.5M	-10.31M	8.07M	46.51M	12M	-16.51M	51.42M	-108.71M
Cash from Financing+	-125.95M	-519.15M	-492.2M	-845.04M	-384.86M	-1.07B	-318.4M	-493.94M	-1.14B	-749.73M
Debt Issued (Net)	711.62M	-102.01M	-53.04M	-17.92M	-160.97M	217.11M	615.95M	99.62M	-429.75M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-38.88M	-38.21M	-37.34M	-53M	-17.34M	-65.9M	-58.45M	-55.48M	-53.35M	-51.27M
Share Repurchases	-353.38M	-364.4M	-397.43M	-770.5M	-206.72M	-1.22B	-832.92M	-547.36M	-670.75M	-967.95M
Other Financing	-27.31M	-14.54M	-4.4M	-3.61M	172K	715K	-42.99M	9.28M	-6.09M	-698.46M
Net Change in Cash	-27.48M	40.68M	32.39M	-94.02M	1.17B	-1.1B	21.9M	13.63M	10.28M	46.57M
Free Cash Flow+	133.26M	573.15M	529.22M	774.95M	1.63B	28.04M	262.02M	524.74M	1.12B	849.25M
FCF Margin %	1.36%	5.51%	4.91%	6.81%	14.07%	0.22%	1.96%	3.67%	7.1%	4.89%
FCF Growth %	23.48%	330.11%	-7.66%	46.43%	109.81%	-98.28%	834.59%	100.27%	114.07%	-24.4%
FCF per Share	1.35	5.95	5.65	8.70	19.00	0.33	3.55	7.48	16.54	13.17
FCF Conversion (FCF/Net Income)	1.83x	1.57x	1.72x	1.77x	2.50x	0.89x	1.47x	1.77x	1.81x	1.25x
Interest Paid	107.08M	135.53M	150.29M	157.41M	112.6M	75.61M	120.14M	200.45M	168.27M	0
Taxes Paid	344.61M	370.86M	293.84M	260.62M	286.25M	362.98M	250.76M	257.9M	325.43M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	15.34%	15.57%	14.81%	14.74%	15.75%	15.73%	11.1%	11.79%	17.62%	21.01%
Return on Invested Capital (ROIC)	11.56%	10.83%	9.59%	9.5%	10.61%	10.21%	6.91%	7.81%	10.95%	12.45%
Gross Margin	89.44%	89.38%	89.15%	89%	88.86%	88.71%	89%	89.27%	89.97%	-
Net Margin	7.19%	7.23%	7.24%	7.16%	8.17%	7.84%	5.04%	5.03%	7.22%	8.57%
Debt / Equity	0.90x	0.80x	0.73x	0.77x	0.65x	0.74x	0.88x	0.87x	0.73x	0.70x
Interest Coverage	10.98x	8.96x	7.58x	7.47x	12.45x	15.99x	7.89x	5.67x	8.97x	12.78x
FCF Conversion	1.83x	1.57x	1.72x	1.77x	2.50x	0.89x	1.47x	1.77x	1.81x	1.25x
Revenue Growth	7.99%	6.59%	3.48%	5.63%	1.59%	9.37%	5.99%	6.59%	10.82%	9.71%

US Stock Screener

...

Universal Health Services, Inc. (UHS) 10-Year Financial Performance & Capital Metrics

UHS •

HealthcareHealthcare FacilitiesHospitals and inpatient facilities

Revenue $17.36B +9.7%
EBITDA $2.61B +15.3%
Net Income $1.49B +30.4%
EPS (Diluted) 23.10 +37.3%
Gross Margin -
EBITDA Margin 15.05% +5.1%
Operating Margin 11.48% +8.1%
Net Margin 8.57% +18.8%
ROE 21.01% +19.3%
ROIC 12.45% +13.7%
Debt/Equity 0.70 -4.8%
Interest Coverage 12.78 +42.5%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Strong Piotroski F-Score: 7/9
✓High quality earnings: Operating CF exceeds net income
✓Good 3Y average ROE of 16.8%
✓Share count reduced 5.1% through buybacks
✓Efficient asset utilization: 1.1x turnover

✗Weaknesses

No significant weaknesses identified

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y6.74%

5Y8.48%

3Y9.03%

TTM9.71%

Profit (Net Income) CAGR

10Y8.14%

5Y9.54%

3Y30.13%

TTM30.36%

EPS CAGR

10Y13.07%

5Y16.02%

3Y36.21%

TTM36.46%

ROCE

10Y Avg12.79%

5Y Avg12.26%

3Y Avg13.38%

Latest16.25%

Peer Comparison

Hospitals and inpatient facilities

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	FCF Yield	Debt/Equity
UHTUniversal Health Realty Income Trust	605.21M	43.62	34.35	-100%	11.84%	11.56%	8.11%
HCAHCA Healthcare, Inc.	118.45B	529.70	18.66	7.08%	8.97%		6.49%
THCTenet Healthcare Corporation	21.04B	239.39	15.45	3.12%	6.6%	15.68%	12.03%	1.47
AUNAAuna S.A.	160.71M	5.34	10.99	14.47%	4.33%	10.05%	100%	2.32
UHSUniversal Health Services, Inc.	2.58M	206.10	8.92	9.71%	8.57%	20.09%	100%	0.70
ARDTArdent Health Partners, LLC	1.34B	9.39	5.94	10.29%	3.24%	12.57%	9.51%	1.50
CYHCommunity Health Systems, Inc.	484.81M	3.46	0.92	-1.18%	4.08%		42.9%
ACHCAcadia Healthcare Company, Inc.	2.12B	23.44	-1.93	5.04%	-33.29%	-51.52%		1.23

Profit & Loss

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Sales/Revenue+	9.77B	10.41B	10.77B	11.38B	11.56B	12.64B	13.4B	14.28B	15.83B	17.36B
Revenue Growth %	7.99%	6.59%	3.48%	5.63%	1.59%	9.37%	5.99%	6.59%	10.82%	9.71%
Cost of Goods Sold+	1.03B	1.11B	1.17B	1.25B	1.29B	1.43B	1.47B	1.53B	1.59B	0
COGS % of Revenue	10.56%	10.62%	10.85%	11%	11.14%	11.29%	11%	10.73%	10.03%	-
Gross Profit+	8.73B	9.3B	9.6B	10.13B	10.27B	11.21B	11.93B	12.75B	14.24B	0
Gross Margin %	89.44%	89.38%	89.15%	89%	88.86%	88.71%	89%	89.27%	89.97%	-
Gross Profit Growth %	8.25%	6.52%	3.21%	5.45%	1.42%	9.19%	6.33%	6.91%	11.69%	-100%
Operating Expenses+	7.45B	8.02B	8.43B	8.91B	8.91B	9.85B	10.92B	11.57B	12.56B	0
OpEx % of Revenue	76.32%	77.09%	78.24%	78.32%	77.1%	77.93%	81.51%	81.04%	79.34%	-
Selling, General & Admin	4.68B	5.08B	5.36B	5.7B	5.73B	6.28B	6.89B	7.25B	7.67B	0
SG&A % of Revenue	47.95%	48.84%	49.76%	50.07%	49.56%	49.7%	51.45%	50.75%	48.43%	-
Research & Development	0	0	0	0	0	0	0	0	0	0
R&D % of Revenue	-	-	-	-	-	-	-	-	-	-
Other Operating Expenses	2.77B	2.94B	3.07B	3.21B	3.18B	3.57B	4.03B	4.33B	4.89B	0
Operating Income+	1.28B	1.28B	1.18B	1.22B	1.36B	1.36B	1B	1.18B	1.68B	1.99B
Operating Margin %	13.12%	12.3%	10.91%	10.69%	11.75%	10.78%	7.49%	8.23%	10.63%	11.48%
Operating Income Growth %	1.75%	-0.1%	-8.2%	3.46%	11.72%	0.35%	-26.38%	17.12%	43.09%	18.56%
EBITDA+	1.7B	1.73B	1.63B	1.71B	1.87B	1.9B	1.59B	1.74B	2.27B	2.61B
EBITDA Margin %	17.39%	16.6%	15.12%	15%	16.17%	15%	11.83%	12.21%	14.32%	15.05%
EBITDA Growth %	2.41%	1.76%	-5.77%	4.79%	9.53%	1.47%	-16.39%	9.97%	30.01%	15.27%
D&A (Non-Cash Add-back)	416.61M	447.76M	453.05M	490.39M	510.49M	533.21M	581.86M	568.04M	584.83M	618.74M
EBIT	1.26B	1.27B	1.18B	1.23B	1.36B	1.38B	993.15M	1.14B	1.68B	0
Net Interest Income+	-116.56M	-142.77M	-154.96M	-162.73M	-106.28M	-83.67M	-126.89M	-206.67M	-186.11M	0
Interest Income	150K	81K	0	0	2.8M	1.6M	378K	572K	1.43M	0
Interest Expense	116.72M	142.85M	154.96M	162.73M	109.09M	85.27M	127.27M	207.25M	187.53M	156.07M
Other Income/Expense	-125.05M	-145.17M	-140.74M	-149.57M	-106.27M	-69.78M	-137.29M	-234.96M	-183.88M	-21.87M
Pretax Income+	1.16B	1.14B	1.03B	1.07B	1.25B	1.29B	866.26M	940.43M	1.5B	1.97B
Pretax Margin %	11.84%	10.9%	9.6%	9.37%	10.83%	10.23%	6.46%	6.58%	9.46%	11.36%
Income Tax+	409.19M	363.7M	236.64M	238.79M	299.29M	305.68M	209.28M	221.12M	334.83M	460.96M
Effective Tax Rate %	60.74%	66.28%	75.37%	76.42%	75.39%	76.67%	77.99%	76.33%	76.24%	75.49%
Net Income+	702.41M	752.3M	779.71M	814.85M	943.95M	991.59M	675.61M	717.79M	1.14B	1.49B
Net Margin %	7.19%	7.23%	7.24%	7.16%	8.17%	7.84%	5.04%	5.03%	7.22%	8.57%
Net Income Growth %	3.22%	7.1%	3.64%	4.51%	15.84%	5.05%	-31.87%	6.24%	59.11%	30.36%
Net Income (Continuing)	747.17M	771.31M	797.88M	827.54M	952.79M	987.63M	656.98M	719.31M	1.16B	1.49B
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	73.69M	68.62M	80.82M	79.1M	89.39M	108.51M	49.46M	52.91M	96.61M	70.62M
EPS (Diluted)+	7.14	7.81	8.32	9.13	10.99	11.82	9.14	10.23	16.82	23.10
EPS Growth %	5.62%	9.38%	6.53%	9.74%	20.37%	7.55%	-22.67%	11.93%	64.42%	37.34%
EPS (Basic)	7.22	7.86	8.36	9.16	11.06	11.99	9.23	10.35	17.16	23.42
Diluted Shares Outstanding	98.38M	96.33M	93.75M	89.04M	85.59M	83.69M	73.83M	70.13M	67.9M	64.46M
Basic Shares Outstanding	97.21M	95.65M	93.28M	88.76M	85.06M	82.52M	73.12M	69.32M	66.55M	63.58M
Dividend Payout Ratio	5.53%	5.08%	4.79%	6.5%	1.84%	6.65%	8.65%	7.73%	4.67%	-

Balance Sheet

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Current Assets+	1.68B	1.8B	1.94B	1.92B	3.28B	2.26B	2.54B	2.81B	2.82B	3.41B
Cash & Short-Term Investments	33.75M	74.42M	105.22M	61.27M	1.22B	115.3M	102.82M	119.44M	125.98M	137.8M
Cash Only	33.75M	74.42M	105.22M	61.27M	1.22B	115.3M	102.82M	119.44M	125.98M	137.8M
Short-Term Investments	0	0	0	0	0	0	0	0	0	0
Accounts Receivable	1.44B	1.5B	1.51B	1.56B	1.73B	1.75B	2.02B	2.24B	2.18B	2.6B
Days Sales Outstanding	53.8	52.63	51.16	50.07	54.6	50.43	54.96	57.2	50.22	54.7
Inventory	125.36M	136.18M	148.21M	159.89M	190.42M	206.84M	218.52M	216.99M	220.94M	0
Days Inventory Outstanding	44.37	44.98	46.29	46.64	53.96	52.9	54.1	51.67	50.79	-
Other Current Assets	82.71M	86.5M	174.47M	133.93M	138.03M	194.78M	198.28M	236.66M	291.61M	667.68M
Total Non-Current Assets+	8.64B	8.96B	9.33B	9.75B	10.2B	10.83B	10.96B	11.16B	11.65B	12.12B
Property, Plant & Equipment	4.33B	4.57B	4.85B	5.34B	5.71B	6.24B	6.37B	6.56B	6.99B	374.24M
Fixed Asset Turnover	2.25x	2.28x	2.22x	2.13x	2.02x	2.03x	2.10x	2.18x	2.26x	46.40x
Goodwill	3.78B	3.83B	3.84B	3.87B	3.88B	3.96B	3.91B	3.93B	3.93B	3.99B
Intangible Assets	0	0	0	0	0	0	0	0	76.27M	0
Long-Term Investments	0	0	0	0	0	0	0	0	318.73M	0
Other Non-Current Assets	520.13M	563.83M	629.83M	523.15M	579.97M	579.9M	605.89M	579.73M	216.19M	7.68B
Total Assets+	10.32B	10.76B	11.27B	11.67B	13.48B	13.09B	13.49B	13.97B	14.47B	15.53B
Asset Turnover	0.95x	0.97x	0.96x	0.98x	0.86x	0.97x	0.99x	1.02x	1.09x	1.12x
Asset Growth %	7.3%	4.3%	4.68%	3.58%	15.5%	-2.84%	3.06%	3.51%	3.6%	7.31%
Total Current Liabilities+	1.32B	1.85B	1.45B	1.56B	2.48B	1.98B	1.91B	2.01B	2.21B	3.24B
Accounts Payable	439.67M	441.98M	445.65M	446.96M	570.52M	658.9M	636.6M	613.97M	632M	750.13M
Days Payables Outstanding	155.6	145.98	139.19	130.37	161.66	168.52	157.6	146.2	145.28	-
Short-Term Debt	105.89M	545.62M	63.45M	87.55M	332M	48.41M	81.45M	126.69M	40.06M	821.39M
Deferred Revenue (Current)	0	0	0	0	376.15M	6K	2.4M	5.38M	0	0
Other Current Liabilities	275.29M	343.22M	472.53M	524.63M	410.17M	466.35M	470.86M	549.47M	622.63M	1.67B
Current Ratio	1.28x	0.97x	1.34x	1.23x	1.32x	1.14x	1.33x	1.40x	1.27x	1.05x
Quick Ratio	1.18x	0.90x	1.24x	1.12x	1.25x	1.04x	1.21x	1.29x	1.17x	1.05x
Cash Conversion Cycle	-57.43	-48.38	-41.74	-33.66	-53.11	-65.19	-48.54	-37.33	-44.27	-
Total Non-Current Liabilities+	4.39B	3.86B	4.35B	4.52B	4.59B	4.91B	5.61B	5.75B	5.5B	4.95B
Long-Term Debt	4.03B	3.49B	3.94B	3.9B	3.52B	4.14B	4.73B	4.79B	4.46B	4.35B
Capital Lease Obligations	0	0	0	270.08M	278.3M	304.62M	395.52M	382.56M	376.24M	0
Deferred Tax Liabilities	88.12M	54.96M	49.66M	25.07M	5.58M	0	0	0	0	5.65M
Other Non-Current Liabilities	275.17M	306.3M	361.81M	329.93M	458.55M	464.76M	487.67M	584.01M	655.81M	598.45M
Total Liabilities	5.71B	5.7B	5.8B	6.09B	7.07B	6.9B	7.52B	7.77B	7.71B	8.19B
Total Debt+	4.14B	4.04B	4B	4.31B	4.19B	4.56B	5.27B	5.37B	4.96B	5.17B
Net Debt	4.1B	3.97B	3.89B	4.25B	2.97B	4.44B	5.17B	5.25B	4.83B	5.03B
Debt / Equity	0.90x	0.80x	0.73x	0.77x	0.65x	0.74x	0.88x	0.87x	0.73x	0.70x
Debt / EBITDA	2.44x	2.34x	2.46x	2.53x	2.24x	2.40x	3.32x	3.08x	2.19x	1.98x
Net Debt / EBITDA	2.42x	2.29x	2.39x	2.49x	1.59x	2.34x	3.26x	3.01x	2.13x	1.92x
Interest Coverage	10.98x	8.96x	7.58x	7.47x	12.45x	15.99x	7.89x	5.67x	8.97x	12.78x
Total Equity+	4.61B	5.06B	5.47B	5.58B	6.41B	6.2B	5.97B	6.2B	6.76B	7.41B
Equity Growth %	1.21%	9.79%	8.14%	2.07%	14.75%	-3.25%	-3.68%	3.88%	9.04%	9.56%
Book Value per Share	46.83	52.51	58.35	62.70	74.85	74.06	80.86	88.44	99.61	114.94
Total Shareholders' Equity	4.53B	4.99B	5.39B	5.5B	6.32B	6.09B	5.92B	6.15B	6.67B	7.34B
Common Stock	966K	942K	914K	867K	851K	771K	710K	672K	650K	7.28B
Retained Earnings	4.89B	4.98B	5.38B	5.47B	6.27B	6.06B	5.93B	6.8B	7.37B	7.99B
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-359.02M	7.18M	4.24M	31.89M	48.12M	30.29M	-9.67M	-650.6M	-706.5M	47.78M
Minority Interest	73.69M	68.62M	80.82M	79.1M	89.39M	108.51M	49.46M	52.91M	96.61M	70.62M

Cash Flow

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Cash from Operations+	1.29B	1.18B	1.34B	1.44B	2.36B	883.7M	996.02M	1.27B	2.07B	1.86B
Operating CF Margin %	13.19%	11.36%	12.45%	12.64%	20.42%	6.99%	7.43%	8.88%	13.06%	10.74%
Operating CF Growth %	26.21%	-8.22%	13.39%	7.28%	64.08%	-62.56%	12.71%	27.29%	63.05%	-9.81%
Net Income	747.17M	771.31M	797.88M	827.54M	952.79M	987.63M	656.98M	717.49M	1.16B	1.51B
Depreciation & Amortization	416.61M	447.88M	453.08M	490.39M	510.49M	533.21M	581.86M	568.04M	584.83M	618.74M
Stock-Based Compensation	48.11M	56.74M	66.58M	69.43M	65.84M	73.69M	85.38M	87.72M	99.35M	95.69M
Deferred Taxes	47.36M	0	49.52M	90.09M	3.32M	26.05M	0	0	0	0
Other Non-Cash Items	-129.33M	-79.19M	-76.15M	-97.78M	-109.76M	0	-83.85M	-124.34M	-198.95M	-361.22M
Working Capital Changes	158.55M	-14.16M	49.98M	58.79M	940.81M	-736.89M	-244.35M	17.07M	418.76M	0
Change in Receivables	-87.88M	-24.72M	-42.24M	-42.06M	-145.9M	-8.87M	-258.34M	-182.44M	67.36M	-317.99M
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	0	0	0	0	0	0	0	0	0	0
Cash from Investing+	-1.19B	-624.4M	-813.4M	-688.41M	-802.56M	-914.47M	-647.3M	-763.27M	-911.11M	-1.07B
Capital Expenditures	-1.16B	-609.43M	-811.67M	-663.52M	-734.21M	-855.66M	-734M	-743.05M	-943.81M	-1.02B
CapEx % of Revenue	11.83%	5.85%	7.53%	5.83%	6.35%	6.77%	5.48%	5.2%	5.96%	5.85%
Acquisitions	-32M	-15.08M	-15.23M	-14.58M	-54.78M	-105.31M	-20.31M	-3.73M	-18.72M	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-32M	108K	13.5M	-10.31M	8.07M	46.51M	12M	-16.51M	51.42M	-108.71M
Cash from Financing+	-125.95M	-519.15M	-492.2M	-845.04M	-384.86M	-1.07B	-318.4M	-493.94M	-1.14B	-749.73M
Debt Issued (Net)	711.62M	-102.01M	-53.04M	-17.92M	-160.97M	217.11M	615.95M	99.62M	-429.75M	0
Equity Issued (Net)	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	-1000K	0
Dividends Paid	-38.88M	-38.21M	-37.34M	-53M	-17.34M	-65.9M	-58.45M	-55.48M	-53.35M	-51.27M
Share Repurchases	-353.38M	-364.4M	-397.43M	-770.5M	-206.72M	-1.22B	-832.92M	-547.36M	-670.75M	-967.95M
Other Financing	-27.31M	-14.54M	-4.4M	-3.61M	172K	715K	-42.99M	9.28M	-6.09M	-698.46M
Net Change in Cash	-27.48M	40.68M	32.39M	-94.02M	1.17B	-1.1B	21.9M	13.63M	10.28M	46.57M
Free Cash Flow+	133.26M	573.15M	529.22M	774.95M	1.63B	28.04M	262.02M	524.74M	1.12B	849.25M
FCF Margin %	1.36%	5.51%	4.91%	6.81%	14.07%	0.22%	1.96%	3.67%	7.1%	4.89%
FCF Growth %	23.48%	330.11%	-7.66%	46.43%	109.81%	-98.28%	834.59%	100.27%	114.07%	-24.4%
FCF per Share	1.35	5.95	5.65	8.70	19.00	0.33	3.55	7.48	16.54	13.17
FCF Conversion (FCF/Net Income)	1.83x	1.57x	1.72x	1.77x	2.50x	0.89x	1.47x	1.77x	1.81x	1.25x
Interest Paid	107.08M	135.53M	150.29M	157.41M	112.6M	75.61M	120.14M	200.45M	168.27M	0
Taxes Paid	344.61M	370.86M	293.84M	260.62M	286.25M	362.98M	250.76M	257.9M	325.43M	0

Key Ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Return on Equity (ROE)	15.34%	15.57%	14.81%	14.74%	15.75%	15.73%	11.1%	11.79%	17.62%	21.01%
Return on Invested Capital (ROIC)	11.56%	10.83%	9.59%	9.5%	10.61%	10.21%	6.91%	7.81%	10.95%	12.45%
Gross Margin	89.44%	89.38%	89.15%	89%	88.86%	88.71%	89%	89.27%	89.97%	-
Net Margin	7.19%	7.23%	7.24%	7.16%	8.17%	7.84%	5.04%	5.03%	7.22%	8.57%
Debt / Equity	0.90x	0.80x	0.73x	0.77x	0.65x	0.74x	0.88x	0.87x	0.73x	0.70x
Interest Coverage	10.98x	8.96x	7.58x	7.47x	12.45x	15.99x	7.89x	5.67x	8.97x	12.78x
FCF Conversion	1.83x	1.57x	1.72x	1.77x	2.50x	0.89x	1.47x	1.77x	1.81x	1.25x
Revenue Growth	7.99%	6.59%	3.48%	5.63%	1.59%	9.37%	5.99%	6.59%	10.82%	9.71%

Universal Health Services, Inc. (UHS) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare UHS vs Peers

vs HCA

vs THC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Universal Health Services, Inc. (UHS) 10-Year Financial Performance & Capital Metrics

Key Insights

✓Strengths

✗Weaknesses

Price & Volume

Growth Metrics

Revenue CAGR

Profit (Net Income) CAGR

EPS CAGR

ROCE

Peer Comparison

Compare UHS vs Peers

vs HCA

vs THC

Compare Top 5

Profit & Loss

Balance Sheet

Cash Flow

Key Ratios

Deep Dive Analysis

Valuation Overview

Total Return Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios